Words

Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Home > Words

At Woodford we have set new standards for communicating with our clients since our establishment in 2014. We never forget whose money we are investing and we believe that investors have a right to understand how their investments are being managed – and also have a choice in how they are communicated with.

Here, you can find out what we’re thinking as we think it and let us have your immediate comments and questions on individual pieces or more generally on our communication programme. Articles are written primarily by our team, with additional contributions from respected industry figures, and feature a mix of articles, thoughts, observations and commentary relating to events and trends in the global financial markets.

We’re keen to ensure our content is of interest and value to our existing and prospective clients so please do get in touch and let us know what you think.

Insights

Patient Capital Trust annual report 2017

Mitchell Fraser-Jones 24 April 2018 14 min read

Following the trial failure announcement from Prothena, today marks the release of the Woodford Patient Capital Trust annual report for 2017. Neil’s review reflects yesterday’s news but as you will read, it should not detract from the progress being demonstrated across much of the rest of the portfolio. The full annual report can also be

Read more

Blog

Prothena: an update

Mitchell Fraser-Jones 23 April 2018 2 min read

We have just heard from Prothena that the Pronto trial has not met its primary endpoint.

Read more

Insights

March roundup

Mitchell Fraser-Jones 3 April 2018 9 min read

March represented another volatile month for global stock markets, with rising concern about the prospect of a trade war between the US and China, appearing to spook the complacent market consensus.

Read more

Insights

Year-to-date roundup

Mitchell Fraser-Jones 1 March 2018 4 min read

It has been a challenging start to the year for the funds and for markets more broadly. In January, we saw a continuation of the themes that have driven markets for much of the last two years now, with momentum firmly in the driving seat as far as share price behaviour was concerned.

Read more

Blog

Capita update

Neil Woodford 2 February 2018 4 min read

Many of you have, understandably, asked for Neil’s current perspective on Capita, following its sharp share price decline earlier this week. Having had a couple of days to reflect and consider what has happened, Neil would like to provide some context…

Read more

Blog

What can investors expect in 2018?

Neil Woodford 19 January 2018 2 min read

In the current climate, it is more important than ever to focus on the broader issues that drive markets. Over the coming weeks and months, we will share with you a more detailed and regular insight into Neil’s thinking…

Read more

Insights

Income Focus Fund update, December 2017

Mitchell Fraser-Jones 19 January 2018 3 min read

We anticipate a very different investment environment to prevail in the year ahead, as macroeconomic conditions increasingly challenge the view of the world that is reflected in financial market valuations.

Read more

Insights

Patient Capital Trust update, December 2017

Mitchell Fraser-Jones 19 January 2018 4 min read

News from the Woodford Patient Capital Trust portfolio in December, including updates on Mereo Biopharma, Xeros and ReNeuron…

Read more

Insights

Equity Income Fund update, December 2017

Mitchell Fraser-Jones 19 January 2018 4 min read

The UK stock market finished the year strongly, following much the same pattern as for 2017 as a whole, with a narrow set of stocks, perceived as beneficiaries of accelerating global growth leading the index higher.

Read more

Blog

Christmas quiz 2017 answers

Mitchell Fraser-Jones 21 December 2017 1 min read

Thank you to all participants in this year’s Christmas quiz. We hope you enjoyed it. We are now pleased to announce the winner as…

Read more

What are the risks?

  • Young businesses have a different risk profile to mature blue-chip companies – risks are much more stock-specific, which implies a lower correlation with equity markets and the wider economy
  • Long-term outcomes are more binary – extremely attractive rewards for success but some businesses will inevitably fail to fulfil their potential and this may expose investors to the risk of capital losses
  • As it can take years for young businesses to fulfil their potential, this investment requires patience
  • The value of the trust as well as any income it pays will fluctuate which may partly be the result of exchange rate changes
  • The price of shares in the trust is determined by market supply and demand, and this may be different to the net asset value of the trust
  • The trust may invest in overseas securities and be exposed to currencies other than pound sterling
  • The trust may invest in unquoted securities, which may be less liquid and more difficult to realise than publicly traded securities

Important information

We do not give investment advice so you need to decide if an investment is suitable for you. If you are unsure whether to invest, you should contact a financial adviser. The trust currently intends to conduct its affairs so that its securities can be recommended by IFAs to ordinary retail investors in accordance with the FCA’s rules in relation to non-mainstream investment products and intends to continue to do so for the foreseeable future. The securities are excluded from the FCA’s restrictions which apply to non-mainstream investment products because they are shares in an investment trust.

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address Beaufort House, 51 New North Road, Exeter, EX4 4EP.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland. The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at www.fundinfo.com.

© 2018 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement